Avidity Biosciences Inc. News, Avidity Biosciences Inc. Quote, RNA Quote

Avidity Biosciences Inc. (NQ:RNA) Delayed: 10.35 -0.16 (1.52%)

Prev. Close

$10.51

Today 6M 1Y 5Y

Open

$10.44

52 Wk High

$22.80

52 Wk Low

$4.12

Day High

$10.74

Day Low

$10.28

P/E

N/A

EPS

$0.00

Volume

421,628

Friends, Peers and Foes (?): RNAM, NVS, BMY, DYN, SNOA (more...)

ALERTS | RSS

Aug 20, 2026 06:24 PM Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 14, 2026 05:47 AM Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
Aug 13, 2026 04:45 PM Atrium Therapeutics Reports Second Quarter 2026 Financial Results
Aug 13, 2026 08:01 AM Atrium Therapeutics receives $15M milestone from Bristol Myers Squibb
Aug 13, 2026 08:00 AM Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Aug 6, 2026 06:09 AM H.C. Wainwright Starts Atrium Therapeutics (RNA) at Buy
Jul 20, 2026 05:58 PM Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jul 14, 2026 06:30 AM FDA clears Atrium Therapeutics IND for rare heart disease drug
Jul 14, 2026 06:30 AM Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
Jun 23, 2026 04:05 PM Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Entities mentioned with RNA

View All Entities